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Na+/Ca2+ Exchanger is a Determinant 
of Excitation–Contraction Coupling in Human Embryonic 
Stem Cell–Derived Ventricular Cardiomyocytes
Ji-Dong Fu,1,2 Peng Jiang,1,2 Stephanie Rushing,1,2 Jing Liu,1,2 Nipavan Chiamvimonvat,3 and Ronald A. Li1,2,4–6
In adult cardiomyocytes (CMs), the Na+/Ca2+ exchanger (NCX) is a well-defi ned determinant of Ca2+ homeo-
stasis. Developmentally, global NCX knockout in mice leads to abnormal myofi brillar organization, electrical 
defects, and early embryonic death. Little is known about the expression and function of NCX in human heart 
development. Self-renewable, pluripotent human embryonic stem cells (hESCs) can serve as an excellent experi-
mental model. However, hESC-derived CMs are highly heterogeneous. A stably lentivirus-transduced hESC line 
(MLC2v-dsRed) was generated to express dsRed under the transcriptional control of the ventricular-restricted 
myosin light chain-2v (MLC2v) promoter. Electrophysiologically, dsRed+ cells differentiated from MLC2v-
dsRed hESCs displayed ventricular action potentials (AP), exclusively. Neither atrial nor pacemaker APs were 
observed. While ICa-L, If, and IKr were robustly expressed, IKs and IK1 were absent in dsRed+ ventricular hESC-
CMs. Upon differentiation (7+40 to +90 days), the basal [Ca2+]i, Ca2+ transient amplitude, maximum upstroke, 
and decay velocities signifi cantly increased (P < 0.05). The ICa-L antagonizer nifedipine (1 μM) decreased the Ca2+ 
transient amplitude (to ~30%) and slowed the kinetics (by ~2-fold), but Ca2+ transients could still be elicited even 
after complete ICa-L blockade, suggesting the presence of additional Ca2+ infl ux(es). Indeed, Ni2+-sensitive INCX 
could be recorded in 7+40- and +90-day dsRed+ hESC-CMs, and its densities increased from −1.2 ± 0.6 pA/pF 
at −120 mV and 3.6 ± 1.0 pA/pF at 60 mV by 6- and 2-folds, respectively. With higher [Ca2+]i, 7+90-day ventric-
ular hESC-CMs spontaneously but irregularly fi red transients upon a single stimulus under an external Na+-free 
condition; however, without extracellular Na+, nifedipine could completely inhibit Ca2+ transients. We conclude 
that INCX is functionally expressed in developing ventricular hESC-CMs and contributes to their excitation–
contraction coupling.
Introduction
Loss of non-regenerative, terminally differentiated cardiomyocytes (CMs) is irreversible; moreover, myocar-
dial repair is hampered by a severe shortage of donor cells 
and organs. Self-renewing pluripotent human embryonic 
stem cells (hESCs) can differentiate in vitro into all 3 prim-
itive germ layers and their derivatives, including CMs [1]. 
Human ESC–derived CMs (hESC-CMs) display molecular, 
structural, and functional properties of early developing 
human fetal CMs [1,2]. Therefore, hESC-CMs may provide 
an unlimited ex vivo source of genuine human CMs for 
transplantation and can also serve as an excellent experi-
mental model for studying human cardiogenesis. However, 
current protocols for cardiac differentiation of hESCs lead 
to a heterogeneous population of pacemaker-, atrial-, and 
ventricular-like derivatives, which are conventionally func-
tionally classifi ed based on their signature action potential 
(AP) profi les [1,3]. Indeed, we previously demonstrated that 
in vivo transplantation of a node of electrically active hESC-
CMs, containing a mixture of ventricular, atrial, and nodal 
cells, into the ventricle can collectively induce a local epicar-
dial pacing origin [2].
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into the 3′ end of the plasmid pLV-EF1α-GFP at the BamHI 
and ClaI restriction sites. EF1α-GFP was kept for selecting 
positively transduced undifferentiated hESCs. For gener-
ating LV particles, the plasmids p∆8.91, pMD.G, and pLV-
MLC2v-dsRed (3:1:2 mass ratio) were co-transfected into 
HEK293T cells seeded at a density of 6 × 106 cells per 10-cm 
dish 24 h prior to transfection. LV particles were harvested 
from the supernatant at 24 and 48 h post-transfection and 
stored at −80°C before use. For transduction, LV particles 
with a titer of 106 and an MOI of 3 and polybrene (6 μg/mL) 
were incubated with cells. A single round of LV transduc-
tion typically yields an effi ciency of >50%.
Isolation of hESC-CMs
For isolating hESC-CMs, dsRed+ outgrowths were micro-
surgically dissected from EBs at 2 stages, 7+30-to-40 days 
(40-day) and 7+80-to-90 days (90-day), by a glass knife [7,11] 
(cf. Fig. 1). The dissected clusters were digested with colla-
genase II (1 mg/mL) at 37°C for 30 min. The isolated cells 
were incubated with KB solution containing (mM): 85 KCl, 
30 K2HPO4, 5 MgSO4, 1 EGTA, 2 Na2-ATP, 5 pyruvic acid, 5 
creatine, 20 taurine, 20 d-glucose, at room temperature for 
30 min. After plating on laminin-coated glass coverslips for 
1 h at 37°C, culture media was added cautiously. To purify 
dsRed+ hESC-CMs, cells were identifi ed by their epifl uores-
cence and sorted by MoFlo (Dako, Ft. Collius, CO).
Isolation of human fetal ventricular 
cardiomyocytes (FLV-CMs)
Human fetal ventricular cardiomyocytes (FLV-CMs) were 
isolated and experimented according to protocols approved 
by the UC Davis IUPAC and IRB (Protocol #200614787-1). In 
brief, fetal human hearts (16–18 weeks, Advanced Bioscience 
Resources, Inc. Alameda, CA) were perfused with enzy-
matic solutions using a customized Langendorff apparatus 
as previously described [7]. FLV-CMs were cultured in lami-
nin-coated 24-well dishes with a density of ~5 × 105 cells/
well with media containing: 5 mM carnitine, 5 mM creatine, 
5 mM taurine, 100 μg/mL penicillin–streptomycin, and 10% 
fetal bovine serum in Medium 199 (Sigma-Aldrich Corp., St. 
Louis, MO).
Immunostaining
Cells were fi xed for 15 min at room temperature with 4% 
paraformaldehyde in PBS. After washing with PBS, cells 
were permeabilized in PBS containing 0.2% Triton X-100, 
then incubated with primary mouse anti-MLC2v or anti-
MLC2a monoclonal antibody. Alexa Fluor-647 anti-mouse 
IgG (Invitrogen) was the second antibody used for fl uo-
rescence imaging. Hoechst 33342 (H3570; Invitrogen) was 
used to stain the nuclei. Coverslips were mounted onto glass 
slides in Prolong Gold antifade reagent (Invitrogen). Samples 
were imaged on a confocal laser scanning microscope (C1si, 
Nikon, Japan).
Electrophysiology
Electrophysiological experiments were performed 
using the whole-cell patch-clamp technique with an 
Axopatch 200B amplifi er and the pClamp9.2 software (Axon 
Sarcolemmal Na+/Ca2+ exchanger (NCX), a bidirectional 
transporter that catalyzes the exchange of 3 or 4 Na+ ions for 
one Ca2+ ion, is a well-defi ned determinant of Ca2+ homeo-
stasis [4]. NCX is responsible for extruding the elevated Ca2+ 
during contraction, thereby restoring a low resting [Ca2+]
i and a high excitation–contraction (E-C)-coupling gain. As 
one of the earliest functional gene products, NCX is known 
to be involved in embryonic heart development and func-
tion. Developmentally, global knockout of NCX in trans-
genic mouse models has been reported to lead to abnormal 
myofi brillar organization, apoptosis, electrical defects, and 
early embryonic death [5,6]. However, little is known about 
the expression and functional profi les of NCX in human 
heart development. We have previously reported that NCX 
is expressed at the protein level by western blot analysis 
in mixed hESC-CMs directly differentiated from hESCs 
by embryoid body formation [7]. But it remains uncer-
tain whether NCX is functional. As such, their biophysical 
properties and contribution to E-C coupling are unknown. 
Since INCX measurements require the inhibition of most ion 
channels (such as K+, Ca2+, and Cl− channels) and chamber-
specifi c CMs differ signifi cantly in their ion channel expres-
sion profi les, it will be necessary to identify and select the 
ventricular derivative for experiments to avoid ambiguities. 
In the present study, we generated an engineered hESC line 
whose ventricular derivatives were fl uorescently labeled, 
followed by patch-clamp recording of INCX and functionally 
assessing its contribution to cytosolic Ca2+ transients and 
E-C coupling.
Materials and Methods
hESC culturing and differentiation
The H1 (WiCells, Madison, WI) hESC line (NIH code: 
WA01) chosen for this study were cultured and differenti-
ated as we previously described [2,7]. In brief, H1 cells were 
grown on irradiated mEFs from 13.5-day embryos of CF-1 
mice and trypsin-propagated. The culture medium consisted 
of 80% DMEM, 20% knockout serum replacement, 4 ng/mL 
basic fi broblast growth factor (b-FGF), 1 mmol/L glutamine, 
0.1 mmol/L β-mercaptoethanol, and 1% nonessential amino 
acid solution (all from Invitrogen, Carlsbad, CA). For differen-
tiation, hESCs were induced to form embryoid bodies (EBs). 
Undifferentiated cells were detached using 1 mg/mL type 
IV collagenase (Gibco-BRL, Carlsbad, CA) and transferred 
to Petri dishes with differentiation media containing 80% 
DMED, 20% fetal bovine serum defi ned (HyClone, Logan, 
UT), 1 mmol/L glutamine, and 1% nonessential amino acid 
without b-FGF. The aggregates were cultured in suspension 
for 7 days, followed by plating on gelatin-coated (0.1%; Sigma-
Aldrich, St. Louis, MO) 60-mm dishes to form hESC-CMs.
Lentivirus-mediated gene transfer
For stable genetic modifi cation, lentivirus (LV)-mediated 
gene transfer was performed as we previously reported [2]. 
To generate pLV-MLC2v-dsRed, a 250-bp fragment of the 
MLC2v promoter carrying the homologous sequence also 
found in rat and human, which has been shown to suffi -
ciently recapitulate the cardiac-specifi c expression pattern 
[8–10], along with a 406-bp region of the human cytomega-
lovirus (CMV) enhancer and the dsRed gene, were inserted 
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stepping to various pre-pulse voltages (−50 to +10 mV, 10 mV 
increments) for 1 s prior to depolarization to a fi xed 250-ms 
test pulse of +10 mV every 10 s. Peak currents obtained at all 
voltages were normalized to the maximal value.
NCX current (INCX) density was determined using the 
whole-cell patch-clamp technique as described previously 
[12]. [Ca2+]i was buffered to 150 nM with BAPTA (calcu-
lated using the Maxchelator program [13]). The external 
solution was K+-free and contained (in mmol/L): Na+ 135, 
Ca2+ 2, MgCl 1, glucose 10, HEPES 10, CsCl 10 (to block the 
inward rectifi er K+ current, IK1, and the Na+/K+ pump), (in 
μmol/L): nifl umic acid 100 (to block Ca2+-activated Cl− cur-
rent), ouabain 10 (Na+/K+ pump inhibitor), and verapamil 
10 (dihydropyridine antagonist), adjusted to pH 7.4 (CsOH). 
The internal solution contained (in mmol/L): CsCl 136, NaCl 
10, aspartic acid 42, MgCl2 3, HEPES 5, tetraethylammonium 
(TEA) 20, MgATP 10, and 150 mM free [Ca2+]i, adjusted to pH 
7.4 (CsOH). The holding potential was −30 mV to inactivate 
the T-type Ca2+ and Na+ channels. Slow-ramp pulses were 
applied (+60 to −120 mV, 0.09 V/s) at 10 s intervals to con-
struct the current−voltage (I/V) relationships. INCX was mea-
sured as the bidirectional Ni2+ (5 mM)-sensitive current.
Measurements of cytosolic Ca2+
Intracellular Ca2+ transients were recorded from dsRed+ 
hESC-CMs as identifi ed by fl uorescence microscope, within 
48 h after plating. A spectrofl uorometric method with Fura-2/
Instruments Inc., Foster City, CA) as previously described 
[3]. A xenon arc lamp was used to view the dsRed fl uores-
cence at 560/590 nm (excitation/emission). Patch pipettes 
were prepared from 1.5 mm thin-walled borosilicate glass 
tubes using a Sutter micropipette puller P-97 and had typi-
cal resistances of 4–6 MΩ. The micropipettes were fi lled with 
an internal solution containing (mmol/L): 110 K+ aspartate, 
20 KCl, 1 MgCl2, 0.1 NaGTP, 5 MgATP, 5 Na2-phospocreatine, 
1 EGTA, 10 HEPES, pH adjusted to 7.3 with KOH. The exter-
nal Tyrode’s bath solution consisted of (mmol/L): 140 NaCl, 5 
KCl, 1 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, pH adjusted to 
7.4 with NaOH. For AP recording, current-clamp recordings 
were performed at 37°C within 24 to 48 h after hESC-CM 
isolation. The hESC-CMs were given a stimulus of 0.1–0.5 
nA for 1–5 ms to elicit AP. Voltage-clamp recordings of ionic 
currents were performed using standard electrophysiologi-
cal and pharmacological isolation.
For measuring the L-type Ca2+ currents (ICa-L), the internal 
solution contained (in mM): 130 CsCl, 1.0 MgCl2, 0.1 NaGTP, 
5 MgATP, 10 HEPES, and 10 EGTA. pH was adjusted to 7.2 
with CsOH. The external solution contained (in mM): 136 
NaCl, 5.4 CsCl, 1.0 MgCl2, 2.0 CaCl2, 2.0 NaH2PO4, 10 glucose, 
and 10 HEPES. pH was adjusted to 7.4 with NaOH, TTX (0.05 
mM) and TEA-Cl (20 mM) were added during the recording, 
and ICa-L was elicited by stepping to various voltages (−50 to 
+10 mV, 10 mV increments, 0.2 Hz) for 100 ms from a holding 
potential of −30 mV, and defi ned as 5 mM nifedipine-sensi-
tive currents. Steady-state inactivation was determined by 
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FIG. 1. DsRed+ cells differentiated from 
stably LV-MLC2v-dsRed-transduced human 
embryonic stem cells (hESCs) displayed a 
ventricular phenotype. (A) Representative 
images of MLC2v-dsRed hESCs differen-
tiating embryoid bodies (EBs) at different 
stages. Beating areas are circled by dash 
lines. Bars represent 50 μm. (B) A represen-
tative single isolated and FACS-sorted 7+90-
day dsRed+ hESC-cardiomyocytes (CMs). 
Bar indicates 20 μm. (C) dsRed+ cells were 
stained positively for MLC2v (upper) but not 
MLC2a staining (lower). Bar indicates 20 μm. 
(D) Typical ventricular action potential (AP) 
recorded from a single dsRed+ hESC-CM. 
Atrial AP could only be observed in non-
dsRed hESC-CMs. (E) ZD7288-sensitive 
pacemaker current (If), but no IK1, were 
expressed in dsRed+ hESC-CMs. (F) E4031-
sensitive IKr, but not IKs, were expressed in 
dsRed+ hESC-CMs. Color images available 
online at www.liebertonline.com/scd.
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anticipated, dsRed+ cells were stained positively for the ven-
tricular isoform (MLC2v), but not the atrial isoform (MLC2a), 
of the myosin light chain (Fig. 1C). Figure 1D further shows 
that functionally only ventricular-like action potentials (AP) 
could be recorded from 40-day dsRed+ cells (n = 15 of 15). 
In contrast, atrial-like APs were observed only in non-dsRed 
cells (5 of 7) isolated from the same beating clusters. The 
hyperpolarization-activated pacemaker current (If) and the 
rapid component of the delayed rectifi er (IKr) were expressed 
in dsRed+ hESC-CMs; but the slow component (IKs) and the 
inward rectifi er (IK1) were not (Fig. 1E and 1F). These results 
were consistent with wild-type hESC-CMs that displayed 
ventricular APs. Therefore, dsRed+ cells differentiated from 
MLC2v-dsRed hESCs belonged to the ventricular lineage. 
Since cardiac differentiation of hESCs is known to generate 
a heterogeneous population of ventricular, atrial, and pace-
maker derivatives [1,3], selection of dsRed+ hESC-CMs for 
experiments will enable us to study the ventricular lineage 
without ambiguities.
Development of Ca2+ transients during ventricular 
hESC-CM differentiation
Ca2+ homeostasis is crucial for E-C coupling and sub-
sequently, the contractile properties of functioning CMs. 
Figure 2 summarizes the Ca2+ transient properties recorded 
from dsRed+ (ventricular) hESC-CMs at different time points 
upon differentiation. From 7+40 to 7+90-day post-differenti-
ation, both the basal [Ca2+]i and Ca2+ transient amplitude sig-
nifi cantly increased (P < 0.05) (Fig. 2A–2C). Ca2+ transients 
of the 7+90-day group also had faster kinetics with higher 
maximum upstroke (Vmax-upstroke; Fig. 2D) and maximum 
decay (Vmax-decay; Fig. 2E) velocities (P < 0.05). Taken together, 
these results demonstrate that Ca2+ transients of ventricu-
lar hESC-CMs appeared to time-dependently mature in cul-
ture, although the adult level was still not reached even after 
almost 100 days.
Contribution of L-type Ca2+ channels to 
Ca2+ transients
In adult CMs, L-type Ca2+ (ICa-L) channels mediate the 
transport of trans-sarcolemmal Ca2+ infl ux for activat-
ing Ca2+ release from the sarcoplasmic reticulum (SR) via 
a process known as Ca2+-induced Ca2+ release (CICR) dur-
ing E-C coupling. In murine ESC-CMs, ICa-L plays a similar 
functional role but the same in ventricular hESC-CMs has 
not been defi ned. Figure 3A and 3B shows that ICa-L was 
robustly expressed in 7+40-day dsRed+ ventricular hESC-
CMs (2.24 ± 0.54 pA/pF at +10 mV; n = 4). The steady-state 
activation (V1/2 = −10.9 ± 0.6 mV, K = 4.6 ± 0.3) and inac-
tivation (V1/2 = −27.1 ± 2.0 mV, K = 7.6 ± 1.3) curves are 
given in Supplementary Figure 2. Upon infusion of nifedi-
pine (1 μmol/L), a selective antagonist of ICa-L, the Ca2+ tran-
sient amplitude decreased to 33.5% ± 9.2% in 40-day (n = 
4) and 28.0% ± 4.6% in 90-day (n = 4) dsRed+ ventricular 
hESC-CMs (Fig. 3C and 3D). The upstroke velocities of Ca2+ 
transients were signifi cantly slowed (Fig. 3E). However, the 
inhibitory effect of nifedipine were not signifi cantly differ-
ent between 7+40-day and 7+90-day dsRed+ ventricular 
hESC-CMs (P > 0.05). Interestingly, Ca2+ transients, albeit 
small in the amplitude (Fig. 3C), could still elicited in both 
7+40- and 7+90-day ventricular hESC-CMs even after ICa-L 
AM as the Ca2+ indicator was used for measuring [Ca2+]i. 
dsRed+ hESC-CMs were incubated with 5 μM Fura-2/AM 
and 0.2% pluronic F-127 for 30 min at 37°C. Fluorescent sig-
nals obtained upon excitation at 340 nm (F340) and 380 nm 
(F380) were recorded from cells perfusing with Tyrode solu-
tion unless otherwise indicated. For Na+-free solution, LiCl 
(140 mM) was used to replace NaCl (140 mM). The F340/F380 
ratio was used to represent cytosolic [Ca2+]i. To elicit cyto-
plasmic Ca2+ transients, hESC-CMs were electrically pulsed 
(0.1–0.5 Hz). Ca2+ transients were recorded and analyzed 
after a series of depolarization that enabled each transient to 
fully decay so as to establish a steady state. Data were ana-
lyzed using the Ionwizard software (Version 5, IonOptix) to 
generate the Ca2+ transient parameters reported [7,11,14].
Statistical analysis
All data were expressed as means ± SEM. One-way 
ANOVA followed by Newman-Keuls multiple comparison 
tests or paired t-test was carried out to test for differences 
between the mean values within the same study. A differ-
ence of P < 0.05 was considered signifi cant.
Results
dsRed+ cells differentiated from stably 
LV-MLC2v-dsRed-transduced hESCs displayed a 
ventricular phenotype
To confi rm the effi cacy of LV-MLC2v-dsRed for identi-
fying ventricular CMs, we fi rst transduced and compared 
human fetal left ventricular (FLV) CMs and human embry-
onic kidney (HEK) 293 cells. FLV-CMs (but not HEK293 
cells) uniquely expressed dsRed after LV-MLC2v-dsRed 
transduction (Supplementary Fig. 1A; Supplementary mate-
rials are available online at http://www.liebertpub.com/), 
indicating the cardiac specifi city of our construct. We next 
generated the stably LV-MLC2v-dsRed-transduced (or 
MLC2v-dsRed) hESC line, whose karyotype was normal 
(Supplementary Fig. 1B). When undifferentiated, absolutely 
no dsRed+ cells could be detected (Supplementary Fig. 1C). 
For differentiation, MLC2v-dsRed hESCs were allowed to 
form EBs for 7 days, followed by plating on gelatin-coated 
culture dishes and observing for the appearance of beating 
clusters and dsRed expression. Same as untransduced con-
trol hESCs that we previously reported [2], spontaneously 
contracting clusters could be observed in EBs differentiated 
from LV-MLC2v-dsRed-transduced hESCs as soon as 10–14 
days after plating (or 7+10–14 days). Furthermore, the per-
centage of EBs containing beating clusters was also not dif-
ferent (12% ± 2% from 10 batches). No dsRed+ cells could 
be observed until beating activities appeared. Indeed, not 
all beating cells were dsRed+ at Day 7+10-to-14. Figure 1A 
shows that dsRed+ cells signifi cantly increased over time, 
with substantially more dsRed+ cells in 7+80-to-90-day EBs. 
Although dsRed+ cells were largely limited to the beating 
clusters at Day 7+40, some non-beating cells also became 
dsRed+ at Day 7+80-to-90.
For functional characterization, we dissected from EBs 
beating clusters that contained dsRed+ cells followed by 
dissociating them into single cells for electrophysiolog-
ical recording. After FACS sorting, a typical single 90-day 
dsRed+ cell after attachment is shown in Figure 1B. As 
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the other isoforms, increased during cardiac differentiation 
from hESCs to hESC-VCMs, peaked in fetal VCMs then 
decreased in adult VCMs. In our previous studies, we have 
also reported that the NCX1 is abundantly expressed in 
unsorted human ESC-CMs at the protein level [7]. However, 
it remains unknown whether INCX is functionally expressed 
in ventricular hESC-CMs. When operating in the reverse 
mode, the NCX current (INCX) can contribute to the eleva-
tion of cytosolic Ca2+ in early developing murine ESC-CMs 
[14] and fetal CMs [15]. Figure 4B shows that Ni2+ (5 mM), 
an inhibitor of NCX, completely abolished Ca2+ transients 
of dsRed+ ventricular hESC-CMs. To test for the func-
tional expression of INCX, we voltage-clamped and compared 
was completely blocked by 10 μmol/L nifedipine (Fig. 3B). 
These results raise the possibility that additional source(s) of 
Ca2+ other than ICa-L is present in ventricular hESC-CMs that 
suffi ce to initiate CICR.
Contribution of NCX to Ca2+ transients during 
human ventricular differentiation
To obtain molecular insights, we next analyzed the tran-
scriptional expression levels of the three NCX isoforms (ie, 
NCX1, 2, and 3) in undifferentiated hESCs, hESC-derived 
ventricular (V) CMs, human fetal VCMs, and adult VCMs. 
Figure 4A shows that only the expression of NCX1, but not 
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inward mode). Signifi cant increases of INCX, particularly in 
the Ca2+ outward mode, were observed in 90-day ventricular 
hESC-CMs (−6.9 ± 1.3 pA/pF or ~6-fold increase at −120 mV 
n = 5 and 7.9 ± 1.3 pA/pF or ~2-fold at 60 mV; P < 0.05).
To explore the functional role of INCX in Ca2+ transients of 
ventricular hESC-CMs, we next applied a Na+-free external 
solution to prevent NCX from extruding Ca2+ [14,16]. Upon 
its perfusion, the basal [Ca2+]i increased signifi cantly in 
7+90-day, but not 7+40-day, dsRed+ ventricular hESC-CMs 
(Fig. 5A and 5B). With a higher cytosolic [Ca2+]i, 7+90-day 
ventricular hESC-CMs spontaneously but irregularly fi red 
Ca2+ transients upon a single stimulus (Fig. 5A). Detailed 
7+40- and 7+90-day dsRed+ ventricular hESC-CMs. Similar 
to previous studies, blockers for K+, Ca2+-activated Cl−, and 
L-type Ca2+ currents, as well as the Na+/K+ pump, were 
added to isolate INCX [12]. Figure 4C shows that INCX, defi ned 
as Ni2+ (5 mM)-sensitive currents, was indeed functionally 
and robustly expressed in 7+40- and 7+90-day dsRed+ ven-
tricular hESC-CMs. A voltage ramp from +60 to −120 mV 
elicited an almost linear current–voltage relationship of INCX 
(Fig. 4D), similar to those previously described for fetal and 
adult mouse CMs [15]. The INCX densities in 40-day ventric-
ular hESC-CMs were −1.2 ± 0.6 pA/pF (n = 4) at −120 mV 
(Ca2+ outward mode) and 3.6 ± 1.0 pA/pF at 60 mV (Ca2+ 
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(10 μmol/L), small Ca2+ transients could be elicited (Fig. 5E). 
Taken collectively, our results strongly suggest that the 
reverse mode of INCX contributes signifi cantly to the Ca2+-
handling properties of developing ventricular hESC-CMs.
Discussion
It is now well-accepted that hESC-CMs differentiated 
from hESCs are highly heterogeneous consisting of ventric-
ular-, atrial-, and pacemaker-like derivatives, fi broblasts, as 
well as extracardiac cell types. Technically, this heteroge-
neity has largely limited their functional characterization 
analysis of the fi rst Ca2+ transient elicited revealed that both 
its Ca2+ transient amplitude and decay velocity reduced to 
76.8% ± 6.2% (n = 4, Fig. 5C) and 38.0% ± 13.9% (n = 4, Fig. 
5D), respectively. Similarly, the Na+-free solution decreased 
the amplitude (to 66.3% ± 5.8%, n = 4) and slowed the decay 
velocity (to 51.6% ± 16.4%, n = 4) of 7+40-day ventricular 
hESC-CMs, although irregular fi ring was not observed. 
Consistently, Ca2+ transients were completely blocked in 
both 7+40- and 7+90-day dsRed+ ventricular hESC-CMs 
cells only when both nifedipine and Na+-free conditions 
were used. Upon reperfusion of the normal Tyrode solution 
(containing 140 mM Na+) even in the presence of nifedipine 
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increased time-dependently; dsRed+ cells could be isolated 
and FACS-sorted into single cells. Patch-clamp recordings 
revealed an AP profi le that is consistent with the ventricular 
phenotype. dsRed+ hESC-CMs were positively immunos-
tained for the cardiac-specifi c proteins cTnI and MHC (data 
not shown). Indeed, Huber et al. recently reported a similar 
strategy to identify hESC-derived ventricular derivatives 
by expressing GFP under the transcriptional control of the 
MLC2v promoter although the functional properties of their 
labeled derivatives were not studied and reported [18].
Compared to adult CMs, fetal CMs have smaller Ca2+ 
transient amplitudes and slower dynamics, and display 
developmental changes during the maturation process [11]. 
In rat and rabbit, cardiac sarcolemmal NCX is abundantly 
expressed and functionally well-developed in late fetal, 
reaches a maximum at perinatal, followed by declining at 
adult stages [19,20]. In developing mouse embryonic CMs, 
functional NCX operates in both Ca2+ inward and outward 
and therefore, our understanding of their biology. Adding 
an extra level of complexity is the fact that although hESCs 
are by defi nition pluripotent, different lines have distinct 
cardiogenic potentials to become early ventricular-, atrial-, 
and pacemaker-like derivatives [3]. For instance, we have 
reported that HES2 cells have a high likelihood of differen-
tiating into ventricular-like hESC-CMs while the atrial-like 
phenotype predominates in H1. Pacemaker-like hESCs were 
always the minority (<5%) [3]. Despite the different distribu-
tions, HES2-derived ventricular-, atrial-, and pacemaker-like 
derivatives display electrophysiological properties compa-
rable to those of H1 once they are differentiated. As such, 
ambiguities exist if chamber-specifi c cells are not selected for 
experiments. In the present study, we employed the classical 
strategy that has been proven for mESCs [9,17] for purifying 
out ventricular hESC-CMs for experiments. Expression of 
dsRed under the transcriptional control of MLC2v appeared 
upon the occurrence of spontaneously beating activities and 
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with ontogeny [31]. Of note, species-dependent differences 
exist for NCX function during development. Ca2+ infl ux by 
NCX contributes to Ca2+ transients even in early-stage dif-
ferentiated hESC-CMs, although NCX exerts no effects on 
Ca2+ transients in early-stage mouse ESC-CMs [14].
Pluripotent hESC-like iPSCs have been recently derived by 
reprogramming adult somatic (fi broblast) cells [32,33]. Using 
protocols originally developed for maintaining and cardiac 
differentiation of hESCs, iPSC can be similarly cultured and 
differentiated into CMs. iPSC-CMs express key cardiac-spe-
cifi c proteins, and spontaneously contract in a manner sim-
ilar to hESC-CMs, and are also heterogeneous with nodal-, 
atrial-, and ventricular-like phenotypes [34]. Our MLC2v-
dsRed-based selection strategy will be useful for charac-
terizing and comparing ventricular iPSC- and hESC-CMs. 
A better understanding of the basic biology of ventricular 
derivatives is crucial for their ultimate clinical application in 
myocardial repair. Additionally, although the Ca2+-handling 
properties of ventricular hESC-CMs appear to mature in cul-
ture in vitro, they did not reach the adult level even after 100 
days. The results further implicate that alternative protocols 
need to be developed for facilitating functional maturation to 
improve both the safety and effi cacy of hESC-CMs.
Conclusion
We have generated the stably LV-transduced MLC2v-
dsRed hESC line and electrophysiologically characterized 
their dsRed+ ventricular derivatives. Based on our present 
results, we conclude that NCX is functionally expressed in, 
and contributes to their Ca2+-handling properties of ventric-
ular hESC-CMs.
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